Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth

1 hour ago 2

Maham Fatima

Thu, March 5, 2026 astatine 10:22 AM CST 2 min read

Solventum Corporation (NYSE:SOLV) is 1 of the cheap caller stocks to bargain now. On February 26, Solventum reported Q4 2025 fiscal results that exceeded expectations, contempt a reported income diminution of 3.7% to $2 billion. This alteration was driven by the divestiture of the company’s Purification and Filtration concern successful September 2025. However, integrated income grew by 3.5%. The institution achieved GAAP diluted EPS of $0.36 and adjusted diluted EPS of $1.57, fueled by indebtedness simplification pursuing the caller divestiture and operational efficiencies that helped offset incremental tariff headwinds.

The MedSurg segment, Solventum’s largest, led the maturation with a 6.2% reported summation successful Infection Prevention and Surgical Solutions. Dental Solutions besides showed beardown momentum with an 8.6% reported income increase, portion Health Information Systems grew by 3.7%. However, the company’s escaped currency travel for the 4th was $33 million, a driblet from the anterior year’s $92 million, reflecting the costs associated with its translation into a standalone entity pursuing its spin-off from 3M.

Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements

Solventum Corporation (NYSE:SOLV) introduced its full-year 2026 guidance, projecting integrated income maturation betwixt 2.0% and 3.0%. This forecast includes an estimated 100-basis-point antagonistic interaction from strategical SKU exits arsenic the institution streamlines its portfolio. Management expects adjusted EPS to scope from $6.40 to $6.60 and anticipates a important betterment successful escaped currency travel to ~$200 million.

Solventum Corporation (NYSE:SOLV) is simply a healthcare institution that develops, manufactures, and commercializes a portfolio of solutions to code captious lawsuit and diligent needs successful the US and internationally. It has 3 segments: Medsurg, Dental Solutions, and Health Information Systems.

While we admit the imaginable of SOLV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Dirt Cheap Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article